Affiliation:
1. Department of Internal Medicine Hamad Medical Corporation Doha Qatar
2. Department of Medical Oncology National Center for Cancer Care and Research Doha Qatar
3. Department of Radiology Hamad Medical Corporation Doha Qatar
Abstract
AbstractThe relationship between chronic myelogenous leukemia (CML) and tuberous sclerosis (TS) is unusual and uncommon. Here, we report a 24‐year‐old woman diagnosed with TS and later identified with CML, as the second case reported with such coexistence, treated with Nilotinib. This article proposes a hypothesis to explain the association. Therefore, we propose Nilotinib for the treatment of patients with such coexisting diseases. Further studies are warranted to reveal the dynamics between these conditions.